ResearcherHarvard UniversityActive in the last 2 years
Lynda Chin
Matched on OpenAlex author ID A5104109623. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 34
2011: 1 paper · 2012: none · 2013: none · 2014: 2 papers · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 6
- Author Correction: Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. Last author DOI 10.1038/s41586-026-10995-6↗
- Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. Last author DOI 10.1038/nature21064↗
- In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer. Co-author DOI 10.1016/j.celrep.2016.05.063↗
- Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer. Co-author DOI 10.1016/j.cell.2014.06.003↗
- Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. Co-author DOI 10.1074/jbc.c113.532267↗
- PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network. Co-author DOI 10.1158/2159-8290.cd-11-0031↗
Closest collaborators
The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ronald Anthony Depinho · 5 shared papers, 2011–2026 · strength 0.31
- Paper Author Correction: Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/s41586-026-10995-6↗
- Paper Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/nature21064↗
- Paper In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determin… DOI 10.1016/j.celrep.2016.05.063↗
- Andrea Viale · 4 shared papers, 2014–2026 · strength 0.29
- Paper Author Correction: Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/s41586-026-10995-6↗
- Paper Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/nature21064↗
- Paper In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determin… DOI 10.1016/j.celrep.2016.05.063↗
- Huamin Wang · 4 shared papers, 2014–2026 · strength 0.29
- Paper Author Correction: Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/s41586-026-10995-6↗
- Paper Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/nature21064↗
- Paper In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determin… DOI 10.1016/j.celrep.2016.05.063↗
- Timothy Paul Heffernan · 4 shared papers, 2014–2026 · strength 0.29
- Paper Author Correction: Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/s41586-026-10995-6↗
- Paper Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/nature21064↗
- Paper In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determin… DOI 10.1016/j.celrep.2016.05.063↗
- Giulio Francesco Draetta · 4 shared papers, 2014–2026 · strength 0.29
- Paper Author Correction: Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/s41586-026-10995-6↗
- Paper Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/nature21064↗
- Paper In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determin… DOI 10.1016/j.celrep.2016.05.063↗
- Haoqiang Ying · 4 shared papers, 2011–2026 · strength 0.27
- Paper Author Correction: Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/s41586-026-10995-6↗
- Paper Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/nature21064↗
- Paper Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer. DOI 10.1016/j.cell.2014.06.003↗
- Alessandro Carugo · 3 shared papers, 2016–2026 · strength 0.26
- Paper Author Correction: Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/s41586-026-10995-6↗
- Paper Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/nature21064↗
- Paper In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determin… DOI 10.1016/j.celrep.2016.05.063↗
- Virginia Giuliani · 3 shared papers, 2016–2026 · strength 0.26
- Paper Author Correction: Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/s41586-026-10995-6↗
- Paper Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/nature21064↗
- Paper In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determin… DOI 10.1016/j.celrep.2016.05.063↗
- Giannicola Genovese · 3 shared papers, 2016–2026 · strength 0.26
- Paper Author Correction: Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/s41586-026-10995-6↗
- Paper Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/nature21064↗
- Paper In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determin… DOI 10.1016/j.celrep.2016.05.063↗
- Jason B. Fleming · 3 shared papers, 2016–2026 · strength 0.26
- Paper Author Correction: Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/s41586-026-10995-6↗
- Paper Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/nature21064↗
- Paper In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determin… DOI 10.1016/j.celrep.2016.05.063↗
- Anirban Maitra · 3 shared papers, 2016–2026 · strength 0.26
- Paper Author Correction: Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/s41586-026-10995-6↗
- Paper Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/nature21064↗
- Paper In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determin… DOI 10.1016/j.celrep.2016.05.063↗
- Marco Dal Molin · 2 shared papers, 2017–2026 · strength 0.23
- Laura DeLong Wood · 2 shared papers, 2017–2026 · strength 0.23
- Michael Goggins · 2 shared papers, 2017–2026 · strength 0.23
- Prasenjit Dey · 2 shared papers, 2017–2026 · strength 0.23
- Tony Gutschner · 2 shared papers, 2017–2026 · strength 0.23
- Jianhua Zhang · 3 shared papers, 2014–2017 · strength 0.11
- Paper Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/nature21064↗
- Paper Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exoso… DOI 10.1074/jbc.c113.532267↗
- Paper Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer. DOI 10.1016/j.cell.2014.06.003↗
- Piergiorgio Pettazzoni · 3 shared papers, 2014–2017 · strength 0.11
- Paper Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. DOI 10.1038/nature21064↗
- Paper In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determin… DOI 10.1016/j.celrep.2016.05.063↗
- Paper Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer. DOI 10.1016/j.cell.2014.06.003↗
- Wantong Yao · 2 shared papers, 2014–2016 · strength 0.07
- Gerald C Chu · 2 shared papers, 2011–2014 · strength 0.05
- Phillip Andrew Futreal · 1 shared paper, 2014 · strength 0.04
- Moritz Koch · 1 shared paper, 2014 · strength 0.04
- Raghu Kalluri · 1 shared paper, 2014 · strength 0.04
- Sónia A. Melo · 1 shared paper, 2014 · strength 0.04
- Christoph Kahlert · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.